[HTML][HTML] The role of inflammation in cardiovascular disease
MY Henein, S Vancheri, G Longo… - International journal of …, 2022 - mdpi.com
Atherosclerosis is a chronic inflammatory disease, in which the immune system has a
prominent role in its development and progression. Inflammation-induced endothelial …
prominent role in its development and progression. Inflammation-induced endothelial …
[HTML][HTML] Coronary microvascular dysfunction
F Vancheri, G Longo, S Vancheri, M Henein - Journal of Clinical …, 2020 - mdpi.com
Many patients with chest pain undergoing coronary angiography do not show significant
obstructive coronary lesions. A substantial proportion of these patients have abnormalities in …
obstructive coronary lesions. A substantial proportion of these patients have abnormalities in …
2018 ESC/EACTS Guidelines on myocardial revascularization
FJ Neumann, M Sousa-Uva, A Ahlsson… - European heart …, 2019 - academic.oup.com
always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …
websites. The National Societies of the ESC are encouraged to endorse, translate, and …
2018 ESC/EACTS Guidelines on myocardial revascularization
M Sousa-Uva, FJ Neumann, A Ahlsson… - European Journal of …, 2019 - academic.oup.com
These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial
Background Symptomatic relief is the primary goal of percutaneous coronary intervention
(PCI) in stable angina and is commonly observed clinically. However, there is no evidence …
(PCI) in stable angina and is commonly observed clinically. However, there is no evidence …
PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week
T Doenst, A Haverich, P Serruys, RO Bonow… - Journal of the American …, 2019 - jacc.org
Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are
considered revascularization procedures, but only CABG can prolong life in stable coronary …
considered revascularization procedures, but only CABG can prolong life in stable coronary …
Prone positioning in awake, nonintubated patients with COVID-19 hypoxemic respiratory failure
AE Thompson, BL Ranard, Y Wei… - JAMA internal medicine, 2020 - jamanetwork.com
Prone Positioning in Awake, Nonintubated Patients With COVID-19 Hypoxemic Respiratory
Failure | Critical Care Medicine | JAMA Internal Medicine | JAMA Network [Skip to Navigation] …
Failure | Critical Care Medicine | JAMA Internal Medicine | JAMA Network [Skip to Navigation] …
[PDF][PDF] 2014 ESC/EACTS Guidelines on myocardial revascularization
Zachęca się pracowników opieki zdrowotnej, aby w pełni uwzględniali te wytyczne
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …
Effect of PCI on long-term survival in patients with stable ischemic heart disease
SP Sedlis, PM Hartigan, KK Teo… - … England Journal of …, 2015 - Mass Medical Soc
Background Percutaneous coronary intervention (PCI) relieves angina in patients with
stable ischemic heart disease, but clinical trials have not shown that it improves survival …
stable ischemic heart disease, but clinical trials have not shown that it improves survival …
The myth of the “vulnerable plaque” transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment
A Arbab-Zadeh, V Fuster - Journal of the American College of Cardiology, 2015 - jacc.org
The cardiovascular science community has pursued the quest to identify vulnerable
atherosclerotic plaque in patients for decades, hoping to prevent acute coronary events …
atherosclerotic plaque in patients for decades, hoping to prevent acute coronary events …